Value of Indium-111 Granulocyte Scintigraphy in the Assessment of Crohn’s Disease of the Small Intestine: Prospective Investigation

Abstract

The present study was undertaken to determine the value of indium-111 granulocyte scintigraphy in Crohn’s disease of the small bowel by comparing the results with those of radiology, endoscopy and surgery. Twenty-one patients with Crohn’s disease of the small bowel, 9 patients with Crohn’s disease of the colon, 1 patient with both localizations and 8 with ulcerative colitis were studied by indium-111 granulocyte scanning. Eighteen patients had evidence of active small intestinal disease based on clinical, radiologic, and/or endoscopic, and/or histopathological features. Thirteen of them had a true positive scan (sensitivity 72%), but accurate assessment of localization and extent of disease was often difficult. Five patients had a false negative scan and 4 a true negative. No false positive scans were found. The diagnostic accuracy was 77%. In contrast, from 18 patients with colonic disease, 16 had a true positive scan corresponding in localization and extent with standard investigations, 1 patient had a false negative scan (sensitivity 94%), and 1 a true negative (diagnostic accuracy 95%). This study also showed that 3–5 h scanning after injection of indium-111-labeled granulocytes is the optimal timing for this test. The patient’s acceptability of this procedure was definitely superior to radiology and endoscopy. In conclusion, this technique has a definite place in evaluating localization and extent of active colonic disease, but it does not replace good small bowel radiology and should not be recommended in the routine diagnostic workup of Crohn’s disease of the small intestine.

Technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy in ulcerative colitis and Crohn's disease

“…In cases of small intestine involvement, our results proved better than those of Crama-Bobouth et al [17]. The difference originated mainly from the different Xray methods.…”

Labelled leucocyte scintigraphy in inflammatory bowel disease: clinical applications.

“…15 17 20 23-25 27 [30][31][32][33] Differences between studies in the proportion of patients with active disease are a major factor in determining the wide variations in the reported sensitivity and accuracy of "'In scanning. Similar results have been reported with 99mTc HMPAO, although identification of various bowel segments is improved because of better image quality.…”

Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease.

“…Also high numbers of peripheral neutrophils, which are capable of producing large amounts of oxygen derived free radicals,5 migrate into the intestinal wall of such patients. 6 Grisham and Granger7 hypothesised that in ulcerative colitis transient ischaemic episodes and subsequent reperfusion produce high levels of free radicals. This process initiates a cascade leading to the recruitment and activation of leucocytes, resulting ultimately in mucosal ulceration.…”